Cabigas, Shekinah Sheen .

HRN: 21-49-65  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2022
CEFUROXIME 750MG (VIAL)
06/05/2022
06/11/2022
IV
485mg
Q8hrs
Pcap C; R/o DF
Waiting Final Action 
06/06/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/06/2022
06/12/2022
PO
7 Ml
TID
AMOEBIASIS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: